FDA recalls eye ointment for improper storage outside label specifications
GenTeal eye ointment (40 boxes, nationwide) recalled due to CGMP storage deviations. Products were stored outside drug label specifications.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for storage deviation without documented illnesses or adverse events. The hazard is precautionary, based on non-compliance with storage specifications rather than proven product harm.
Plain-English summary
GenTeal Tears Lubricant Eye Ointment, 3.5 gm boxes (NDC 0065-0518-01), has been recalled by McKesson Medical-Surgical Inc. Approximately 40 boxes were affected and distributed nationwide. The product is identified by Part# 30065051801.
The recall was issued due to Current Good Manufacturing Practice (CGMP) deviations. The recalled products were stored outside the conditions specified on the drug label.
Consumers who have this product should verify whether they possess any affected units and contact McKesson Medical-Surgical Inc. or the FDA for guidance on appropriate action.
The recalled product
- Product
- GENTEAL (MINERAL OIL, WHITE PETROLATUM)
- Brand
- GENTEAL
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Ophthalmic
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Part# 30065051801
UPCs (1)
- 0300650518017
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27